Literature DB >> 206906

Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.

G Orth, S Jablonska, M Favre, O Croissant, M Jarzabek-Chorzelska, G Rzesa.   

Abstract

Human papillomaviruses (HPVs) found in lesions of 11 patients suffering from epidermodysplasia verruciformis were compared to HPV type 1 (HPV-1) and HPV type 2 (HPV-2) previously characterized in plantar and common warts, respectively. Complementary RNAs (cRNAs) to HPV-1, HPV-2, and viruses obtained from two patients with epidermodysplasia verruciformis (J.D. HPV and J.K. HPV) were used in cRNA.DNA filter hybridization experiments. No sequence homology was detected between HPV-1 or HPV-2 DNAs and DNAs obtained from the 11 epidermodysplasia verruciformis HPV isolates. Furthermore, with J.D. and J.K. HPV cRNAs, epidermodysplasia verruciformis HPV DNAs fell into two groups showing little, if any, sequence homology. A lower extent of annealing was observed for the DNAs of some isolates showing a genetic heterogeneity within each of the two groups. Almost no antigenic crossreaction was detected by immunodiffusion and indirect immunofluorescence tests, either between epidermodysplasia verruciformis HPVs and HPV-1 or HPV-2 or between J.D. and J.K. HPVs. Viruses belonging to the same group have common antigenic properties, but antigenic differences were observed when two of the viruses sharing only partial DNA sequence homology were compared. Viruses related to J.D. HPV were preferentially associated with flat wart-like lesions of epidermodysplasia verruciformis and were further found in the lesions of five patients bearing multiple flat warts. Viruses related to J.K. HPV were found in morphologically distinct lesions (red spots) present in some patients with epidermodysplasia verruciformis. Thus, we propose to distinguish two other types of HPVs designated provisionally as HPV type 3 (HPV-3) and HPV type 4 (HPV-4), with J.D. and J.K. HPVs as prototypes, respectively. Malignant conversion of some epidermodysplasia verruciformis lesions is more frequently associated with HPV-4 than with HPV-3 infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206906      PMCID: PMC411508          DOI: 10.1073/pnas.75.3.1537

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Nucleotide sequence of bacteriophage phi X174 DNA.

Authors:  F Sanger; G M Air; B G Barrell; N L Brown; A R Coulson; C A Fiddes; C A Hutchison; P M Slocombe; M Smith
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

2.  Behavior of virus in malignant degeneration of skin lesion in epidermodysplasia verruciformis.

Authors:  M Ruiter; P J van Mullem
Journal:  J Invest Dermatol       Date:  1970-04       Impact factor: 8.551

3.  Epidermodysplasia verruciformis and epidermoid carcinoma. Electron microscopic observations.

Authors:  C M Aaronson; M A Lutzner
Journal:  JAMA       Date:  1967-09-04       Impact factor: 56.272

4.  Human papilloma viruses (HPV): characterization of four different isolates.

Authors:  L Gissmann; H Pfister; H Zur Hausen
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

5.  Familial epidermodysplasia verruciformis of Lewandowsky and Lutz.

Authors:  K Rajagopalan; J Bahru; D S Loo; C H Tay; K N Chin; K K Tan
Journal:  Arch Dermatol       Date:  1972-01

6.  Cell-mediated immunity in epidermodysplasia verruciformis.

Authors:  W Gliński; S Jablonska; A Langner; S Obalek; M Haftek; M Proniewska
Journal:  Dermatologica       Date:  1976

7.  A case report including EM and DNA repair investigations in a dermatosis associated with multiple skin cancers: epidermodysplasia verruciformis.

Authors:  H Hammar; L Hammar; L Lambert; U Ringborg
Journal:  Acta Med Scand       Date:  1976

8.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses.

Authors:  M Favre; F Breitburd; O Croissant; G Orth
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

10.  Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis.

Authors:  F Pass; M Reissig; K V Shah; M Eisinger; G Orth
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

View more
  53 in total

1.  Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses.

Authors:  G Orth; M Favre; S Majewski; S Jablonska
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  [HPV-induced diseases].

Authors:  A Rübben
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

3.  [Clinical algorithm of cutaneous extragenital wart treatment].

Authors:  A Rübben
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

Review 4.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  [Atypical cutaneous infections with genital HPV].

Authors:  E-I Grussendorf-Conen
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

6.  HPV researchers set sights on preventing skin cancers.

Authors:  Simon Grose
Journal:  Nat Med       Date:  2009-01       Impact factor: 53.440

Review 7.  Role of papillomaviruses.

Authors:  F Chang
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

Review 8.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 9.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

Review 10.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.